<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03889470</url>
  </required_header>
  <id_info>
    <org_study_id>HerminaHCKRAS</org_study_id>
    <nct_id>NCT03889470</nct_id>
  </id_info>
  <brief_title>Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center</brief_title>
  <acronym>NORAS</acronym>
  <official_title>A Randomized Comparison of Nitroglycerin Versus Placebo as Spasmolytic Regimen to Prevent Moderate to Severe Radial Artery Spasm in Radial Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hermina Heart Center Kemayoran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hermina Heart Center Kemayoran</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will investigate whether administration of Nitroglycerin (NTG) as
      spasmolytic regimen reduces the incidence of moderate to severe radial artery spasm (RAS) in
      patients undergoing transradial catheterization in radial center.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomized to receive either 200 microgram NTG or placebo (saline) at the
      beginning of the procedure soon after radial sheath placement. The operators will be blinded
      to both assignment. The primary outcome is the incidence of moderate to severe RAS evaluated
      by the operators during the radial procedure.

      Both NTG and placebo will be administered using an identical syringe to keep the operators
      blinded to the treatment allocation. Radial angiogram is mandatory to measure the diameter of
      both radial and ulnar arteries. Doppler ultrasound of the radial artery will be examined at
      the day after the procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 31, 2018</start_date>
  <completion_date type="Anticipated">October 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>NTG vs Placebo</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of Moderate to severe radial artery spasm</measure>
    <time_frame>During the index procedure</time_frame>
    <description>arm pain associated with catheter manipulation (RAS grade 2 to 4)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Radial Artery Injury</condition>
  <arm_group>
    <arm_group_label>200 microgram NTG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 microgram NTG through the radial sheath</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline infusion through the radial sheath</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NTG 1 MG/ML Injectable Solution</intervention_name>
    <description>administered after sheath placement</description>
    <arm_group_label>200 microgram NTG</arm_group_label>
    <arm_group_label>Saline</arm_group_label>
    <other_name>Nitroglycerin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients undergoing transradial catheterisation using proximal radial artery
             puncture technique

        Exclusion Criteria:

          -  Blood pressure &lt;100 mmHg

          -  Refuse to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Agnes Intan, MD</last_name>
    <phone>622122608047</phone>
    <phone_ext>1234</phone_ext>
    <email>agnesintan1231@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hermina Heart Center</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10630</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Surya Dharma, MD, PhD</last_name>
      <phone>+622122608771</phone>
      <phone_ext>9</phone_ext>
      <email>drsuryadharma@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>March 22, 2019</study_first_submitted>
  <study_first_submitted_qc>March 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2019</study_first_posted>
  <last_update_submitted>June 1, 2019</last_update_submitted>
  <last_update_submitted_qc>June 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hermina Heart Center Kemayoran</investigator_affiliation>
    <investigator_full_name>Surya Dharma, MD, PhD</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>transradial catheterisation</keyword>
  <keyword>radial artery spasm</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

